1. Home
  2. AVAH vs NRIX Comparison

AVAH vs NRIX Comparison

Compare AVAH & NRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aveanna Healthcare Holdings Inc.

AVAH

Aveanna Healthcare Holdings Inc.

N/A

Current Price

$11.01

Market Cap

2.7B

Sector

Health Care

ML Signal

N/A

Logo Nurix Therapeutics Inc.

NRIX

Nurix Therapeutics Inc.

N/A

Current Price

$12.94

Market Cap

2.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AVAH
NRIX
Founded
1984
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Hospital/Nursing Management
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.8B
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
AVAH
NRIX
Price
$11.01
$12.94
Analyst Decision
Buy
Buy
Analyst Count
11
14
Target Price
$15.20
★ $33.50
AVG Volume (30 Days)
2.1M
★ 3.1M
Earning Date
11-12-2026
10-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 1850.00
N/A
EPS
0.57
★ 3.26
Revenue
★ $2,433,199,000.00
$76,987,000.00
Revenue This Year
$11.36
$786.93
Revenue Next Year
$7.58
N/A
P/E Ratio
$18.81
★ $4.17
Revenue Growth
20.19
★ 99.31
52 Week Low
$5.93
$13.55
52 Week High
$14.71
$28.23

Technical Indicators

Market Signals
Indicator
AVAH
NRIX
Relative Strength Index (RSI) 31.53 21.08
Support Level $8.91 N/A
Resistance Level $13.76 $17.23
Average True Range (ATR) 0.71 1.07
MACD -0.28 -0.47
Stochastic Oscillator 11.22 0.22

Price Performance

Historical Comparison
AVAH
NRIX

About AVAH Aveanna Healthcare Holdings Inc.

Aveanna Healthcare Holdings Inc is a diversified home care platform that provides care to medically complex, high-cost patient populations. It directly addresses the pressing challenges facing the U.S. healthcare system by providing safe, high-quality care in the home. The firm provides its services through three segments: Private Duty Services (PDS); Home Health & Hospice (HHH); and Medical Solutions (MS). The Private Duty Services segment generates the majority of revenue, which includes private duty skilled nursing services, non-clinical and personal care services, and pediatric therapy services, and is principally reimbursed by Medicaid and Medicaid MCO.

About NRIX Nurix Therapeutics Inc.

Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.

Share on Social Networks: